Changzhou Institute of Materia Medica Co., Ltd.

Changzhou Institute of Materia Medica Co., Ltd. was established in November 2010. Its predecessor was the state-owned scientific research unit: Changzhou Institute of Materia Medica, which was founded in 1984. It is mainly engaged in the production of medical devices and the development of synthetic drug products, process design, technology transfer, and technical consultation. , technical training, etc. In 2010, Changzhou Institute of Materia Medica was restructured and transformed into an enterprise, and its name was changed to "Changzhou Institute of Materia Medica Co., Ltd." In July 2015, a modern biopharmaceutical production base that complies with the new version of GMP has been built in Changzhou Life and Health Industrial Park, covering an area of 53.4 mu.

Visit Website

Manufacturer

Ji Chun(CEO)

Sodium hyaluronate, hyaluronic acid

Above 10M USD

5

Changzhou Institute of Materia Medica Co., Ltd., originally established as the Changzhou Institute of Materia Medica in 1984 under state ownership, underwent restructuring in November 2010 to become a privately owned enterprise. Specializing in the production of medical devices and the development of synthetic drug products, the company offers services including process design, technology transfer, technical consultation, and training. Located in Changzhou City, Jiangsu Province, the company operates from its modern biopharmaceutical production base within the Changzhou Life and Health Industrial Park, spanning 53.4 mu. This facility adheres to the latest Good Manufacturing Practice (GMP) standards, ensuring compliance with stringent quality and safety protocols. Changzhou Institute of Materia Medica Co., Ltd. is committed to advancing research and innovation in biomaterials such as sodium hyaluronate, hyaluronic acid, gel, collagen, and chitosan, contributing to the development and production of high-quality medical products.